{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-questionFirstAnswered.=2014-10-21T15%3A45%3A44.866352Z&legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Weaver+Vale&min-ddpCreated=2016-10-24T21%3A52%3A18.320Z&min-ddpModified.=2016-11-22T14%3A55%3A02.905Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptShortName=Health&min-questionFirstAnswered.=2014-10-21T15%3A45%3A44.866352Z&legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Weaver+Vale&min-ddpCreated=2016-10-24T21%3A52%3A18.320Z&min-ddpModified.=2016-11-22T14%3A55%3A02.905Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-questionFirstAnswered.=2014-10-21T15%3A45%3A44.866352Z&legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Weaver+Vale&min-ddpCreated=2016-10-24T21%3A52%3A18.320Z&_metadata=all&min-ddpModified.=2016-11-22T14%3A55%3A02.905Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&_page=0&min-questionFirstAnswered.=2014-10-21T15%3A45%3A44.866352Z&legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Weaver+Vale&min-ddpCreated=2016-10-24T21%3A52%3A18.320Z&min-ddpModified.=2016-11-22T14%3A55%3A02.905Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-questionFirstAnswered.=2014-10-21T15%3A45%3A44.866352Z&legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Weaver+Vale&min-ddpCreated=2016-10-24T21%3A52%3A18.320Z&min-ddpModified.=2016-11-22T14%3A55%3A02.905Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&min-questionFirstAnswered.=2014-10-21T15%3A45%3A44.866352Z&legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Weaver+Vale&min-ddpCreated=2016-10-24T21%3A52%3A18.320Z&min-ddpModified.=2016-11-22T14%3A55%3A02.905Z", "items" : [{"_about" : "http://data.parliament.uk/resources/816844", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/816844/answer", "answerText" : {"_value" : "
The Department has not received any queries on behalf of general practitioners about diamorphine supplies. However, we are aware that supply issues do occasionally occur with prescription drugs. The Department works closely with the Medicines and Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England, clinical experts, and others operating in the supply chain to help prevent shortages and to ensure that the impact on patients is minimised when they do arise.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-01-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-01-10T11:14:34.44Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2018-01-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Prescription Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, whether he has received any representations on difficulties experienced by GPs in obtaining (a) diamorphine and (b) other prescription drugs; and whether he is taking steps to increase the ease of access to such drugs by GPs.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4667", "label" : {"_value" : "Biography information for Mike Amesbury"} } , "tablingMemberConstituency" : {"_value" : "Weaver Vale"} , "tablingMemberPrinted" : [{"_value" : "Mike Amesbury"} ], "uin" : "121271"} , {"_about" : "http://data.parliament.uk/resources/786234", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/786234/answer", "answerText" : {"_value" : "
No such assessment has been made.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2017-11-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-11-13T17:29:00.717Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-11-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Health Hazards: Young People"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what assessment his Department has made of any risks to the health of 16 to 18-year olds that may be caused by voting.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4667", "label" : {"_value" : "Biography information for Mike Amesbury"} } , "tablingMemberConstituency" : {"_value" : "Weaver Vale"} , "tablingMemberPrinted" : [{"_value" : "Mike Amesbury"} ], "uin" : "111907"} , {"_about" : "http://data.parliament.uk/resources/782790", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/782790/answer", "answerText" : {"_value" : "
On 24 February 2016, the National Institute for Health and Care Excellence published a new best practice guideline on the assessment and management of Motor Neurone Disease (MND). The guideline sets out the signs and symptoms of the disease and recommends that robust protocols and pathways are in place to inform healthcare professionals about MND, how it may present and to inform healthcare professionals in all settings about local referral arrangements. The guideline can be found by following the link below:<\/p>